StockData
MAIA Biotechnology, Inc. logo

MAIA Biotechnology, Inc. (MAIA) stock

MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$1.30+0.05 (+4.00%)

Close on Nov 18, 2026Market cap $79.07MP/E –Yield –

MAIA Biotechnology operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

MAIA Biotechnology's operating cash flow for the twelve months ending Jun 30, 2026 was -$22.57M. For fiscal 2025 it was -$18.84M. The highest annual figure on record is -$4.12M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$18.84M–
FY2024Dec 31, 2024-$15.70M–
FY2023Dec 31, 2023-$13.07M–
FY2022Dec 31, 2022-$12.10M–
FY2021Dec 31, 2021-$4.12M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.75M–
Q1 FY2026Mar 31, 2026-$5.31M–
Q4 FY2025Dec 31, 2025-$7.02M–
Q3 FY2025Sep 30, 2025-$3.49M–
Q2 FY2025Jun 30, 2025-$4.14M–
Q1 FY2025Mar 31, 2025-$4.20M–
Q4 FY2024Dec 31, 2024-$3.91M–
Q3 FY2024Sep 30, 2024-$3.52M–
Q2 FY2024Jun 30, 2024-$4.68M–
Q1 FY2024Mar 31, 2024-$3.59M–
Q4 FY2023Dec 31, 2023-$3.99M–
Q3 FY2023Sep 30, 2023-$3.16M–
Q2 FY2023Jun 30, 2023-$2.56M–
Q1 FY2023Mar 31, 2023-$3.36M–
Q4 FY2022Dec 31, 2022-$2.95M–
Q3 FY2022Sep 30, 2022-$4.32M–
Q2 FY2022Jun 30, 2022-$2.02M–
Q1 FY2022Mar 31, 2022-$2.81M–
Q4 FY2021Dec 31, 2021-$1.61M–
Q3 FY2021Sep 30, 2021-$1.31M–

More MAIA Biotechnology figures

See a number that looks wrong?